Literature DB >> 15291825

The validity of the Mathias criteria for establishing occupational causation and aggravation of contact dermatitis.

Arieh Ingber1, Sharon Merims.   

Abstract

Mathias proposed 7 criteria for establishing occupational causation and aggravation of contact dermatitis (Mathias, J Am Acad Dermatol 1989, 20, 842-848). 4 of the 7 criteria must be positive to conclude occupational dermatitis. In order to evaluate the validity of these criteria, we re-examined 19 patients (17 male and 2 female) with contact dermatitis, who had given a positive answer to at least 4 of the criteria and had either exchanged their workplace or stopped working. We re-evaluated them, 2-5 years later, for the presence of contact dermatitis. 14 of 19 patients (74%) reported that their dermatitis had cleared after they had left their previous workplace. Only 5 patients still suffered from dermatitis, 2-5 years later. 3 of these 5 patients could have been exposed to the causative allergens in their new workplace. We conclude that the Mathias criteria are useful to assess occupational contact dermatitis.

Entities:  

Mesh:

Year:  2004        PMID: 15291825     DOI: 10.1111/j.0105-1873.2004.00273.x

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  3 in total

Review 1.  Occupational Dermatosis.

Authors:  Dorothy Linn Holness
Journal:  Curr Allergy Asthma Rep       Date:  2019-07-27       Impact factor: 4.806

Review 2.  Occupational Contact Dermatitis: An Individualized Approach to the Worker with Dermatitis.

Authors:  Marie-Claude Houle; D Linn Holness; Joel DeKoven
Journal:  Curr Dermatol Rep       Date:  2021-09-14

3.  Occupational contact dermatitis: analysis of cases observed in a service not specialized in occupational dermatosis between 2004 and 2017.

Authors:  Rosana Lazzarini; Mariana de Figueiredo Silva Hafner; Nathalie Mie Suzukia; Isabela Marangon Pasotti; Maria Regina de Paula Leite Kraft
Journal:  An Bras Dermatol       Date:  2021-12-04       Impact factor: 1.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.